Survival of primary irradiated patients with NSCLC in dependence of the pretherapeutical haemoglobin level;Uberlebenszeiten ausschliesslich bestrahlter NSCLCL-Patienten: Die bedeutung des pratherapeutischen hamoglobinwerts

Strahlentherapie und Onkologie

Volumn 174, Issue 3, 1998, Pages 128-132

  Wilhelm, R ^a   Kovacs G ^a,b   Heinrichsohn, D ^a   Galalae, R ^a   Kimmig, B ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Anemia; Haemoglobin; Non small cell lung cancer (NSCLC); Radiotherapy; Survival

Indexed keywords

AGE; ANEMIA; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HEMOGLOBIN DETERMINATION; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RADIATION DOSE; RADIATION RESPONSE; SEX DIFFERENCE; TREATMENT OUTCOME; ADENOCARCINOMA; BLOOD; COMPARATIVE STUDY; LARGE CELL CARCINOMA; LUNG TUMOR; MORTALITY; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TIME;

HEMOGLOBIN;

ADENOCARCINOMA; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; HEMOGLOBINS; HUMANS; LUNG NEOPLASMS; MALE; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0032013025     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03038495     Document Type: Article

References (21)

1. Acht MJJ van, Leer JWH, Hermanns J, Box D. The prognostic value of haemoglobin content during radiotherapy in patients with laryngeal cancer. 9th ESTRO Annual Meeting, Montecatini Terme, 12-15 September 1990:60.program and abstracts.
2. Busch RS, Jenkin RDT, Allt WEC et al. Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer 1976;37:Suppl III:302-6.
3. Dische S, Anderson PJ, Saely R, Watson ER. Carcinoma of the cervix - anemia, radiotherapy and hyperbaric oxygen. Br J Radiol 1983;56:251-4.
4. Dosoretz DE, Katin MJ, Blitzer PH et al. Medically inoperable lung carcinoma: the role of radiation therapy. Semin Radiat Oncol 1996;6:98-104.
5. Dowlati A, R'Zik S, Fillet G, Beguin Y. Anaemia of lung cancer is due to impaired erythroid marrow response to erythropoietin stimulation as well as relative inadequacy of erythropoietin production. Br J Haematol 1997;97:297-9.
6. Dubrai B, Mosseri V, Brunin F et al. Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study. Radiology 1996;201:553-8.
7. Eichorn HJ. Five-year results by intensive nigh voltage therapy of inoperable bronchial carcinoma. Eur J Cancer 1980;16:1591-6.
8. Freedmann LS, Honess DJ, Bleehen NM, Adams GE, Dische S, Henk JM. Does initial haemoglobin level modify the efficacy of radiosensitizers? An analysis of the MRC misonidazole studies in head and neck cancer and cervix cancer. Im J Radiat Oncol Biol Phys 1987;52:965-7.
9. Hall E, Fowler JF. Radiobiology. Int J Radiat Oncol Biol Phys 1988; 14:Suppl 1:25-7.
10. Hill RP, Busch RS, Yeung P. The effect of anaemia on the fraction of hyporic cells in an experimental tumor. Br J Radiol 1971;44:229-304.
11. Kudo K, Nagata M, Hayashi N et al. Retrospective clinical evaluation of prognosis factors in stage D2 prostatic cancer treated with endocrine therapy. Hinyokika Kiyo 1991;37:129-34.
12. Mould RF. Introductory medical statistics, 2nd edn. Bristol-Philadelphia: Institute of Physics Publishing, 1994.
13. Noordijk EM, Poest Clement E v d, Hermans J, Wever AMJ, Leer JWH. Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. Radiother Oncol 1988;13:83-9.
14. Oehler W, Fischer J, Merkle K. Beeinflußt der initiale Hämoglobinwert die Primärtumorreaktion? Eine Untersuchung an 264 bestrahlten Bronchialkarzinomen. Radiobiol Radiother 1990;31:524-31.
15. Overgaard JA, Anderson P, Jorgensen K et al. Misonidazole as an adjuvant to radiotherapy in the treatment of invasive carcinoma of the larynx and pharynx. 2nd Internim analysis of the Danish Head and Neck cancer study (DAHANCA)-Protocol 2. In: Kärcher KH, Hrsg. Progress in Radio-Oncology III. Wien: Hoffmann, 1985:137.
16. Revesz L, Balmukhanov S. Anaemia as a prognostic factor for the therapeutic effect of radiosertsitizers. Int J Radiol Biol 1987;51:591-5.
17. Révész L, Schiraczka E, Balmukhanov S. Gefäßdichte in Tumoren: Ihr mǒglicher prognostischer Wert und therapeutischer Wen. Strahlenther Onkol 1986;162:639-41.
18. Sandler HM, Curran WJ Jr., Turrisi AT III: The influence of tumour size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1990;19:9-13.
19. Sutherland RM, Ausserer WA, Murphy BJ, Laderoute KR. Tumor hypoxia and heterogeneity: challenges and opportunities for the future. Semin Radiat Oncol 1996;6:59-70.
20. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955;9:539-41.
21. Wigren T, Oksanen H, Kellokumpu-Lehtinen P. A practical prognostic index for inoperable non-small-cell lung cancer. J Cancer Res Clin Oncol 1997;123:259-66.